Literature DB >> 3258467

Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry).

A Cameron1, M J Schwartz, R A Kronmal, A S Kosinski.   

Abstract

Estimates of the prevalence of atrial fibrillation (AF) in patients with coronary artery disease have varied from "frequent" to less than 2%. Data on 18,343 patients with angiographically demonstrated CAD in the Coronary Artery Surgery Study (CASS) registry were reviewed and AF was found to be present in 116 (0.6%) patients. The presence of AF was positively associated with the following clinical and angiographic variables: older age, sex (male), mitral regurgitation and functional impairment due to congestive heart failure. The number of diseased coronary arteries was negatively related to the presence of AF. Atrial fibrillation was an independent predictor of survival and its presence doubled the estimated risk over those patients without AF.

Entities:  

Mesh：

Year:  1988        PMID： 3258467     DOI： 10.1016/0002-9149(88)91053-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  22 in total

Review 1.  Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management.

Authors:  I Savelieva; A J Camm
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

2.  Coronary heart disease and atrial fibrillation. Studies have not shown a causal relation.

Authors:  N Wheeldon
Journal:  BMJ       Date:  1996-03-09

3.  Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation.

Authors:  A E Tuinenburg; I C Van Gelder; M P Van Den Berg; J Brügemann; P J De Kam; H J Crijns
Journal:  Heart       Date:  1999-10       Impact factor: 5.994

4.  Cardiovascular risk factors, ECG abnormalities and quality of life in subjects with atrial fibrillation.

Authors:  J Gehring; S Perz; J Stieber; R Küfner; U Keil
Journal:  Soz Praventivmed       Date:  1996

Review 5.  Gender and cardiac arrhythmias.

Authors:  R P Villareal; A L Woodruff; A Massumi
Journal:  Tex Heart Inst J       Date:  2001

Review 6.  Clinical significance of atrial fibrillation in hypertrophic cardiomyopathy.

Authors:  I Olivotto; B J Maron; F Cecchi
Journal:  Curr Cardiol Rep       Date:  2001-03       Impact factor: 2.931

7.  Automatic cardiac event recorders reveal paroxysmal atrial fibrillation after unexplained strokes or transient ischemic attacks.

Authors:  Jean-Claude Barthélémy; Séverine Féasson-Gérard; Pierre Garnier; Jean-Michel Gaspoz; Antoine Da Costa; Daniel Michel; Frédéric Roche
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-07       Impact factor: 1.468

8.  An 8 1/2-year clinical experience with surgery for atrial fibrillation.

Authors:  J L Cox; R B Schuessler; D G Lappas; J P Boineau
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

9.  Management of refractory atrial fibrillation post surgical ablation.

Authors:  Robert K Altman; Riccardo Proietti; Conor D Barrett; Alessandro Paoletti Perini; Pasquale Santangeli; Stephan B Danik; Luigi Di Biase; Andrea Natale
Journal:  Ann Cardiothorac Surg       Date:  2014-01

Review 10.  Prediction of atrial fibrillation development and progression: Current perspectives.

Authors:  Konstantinos Vlachos; Konstantinos P Letsas; Panagiotis Korantzopoulos; Tong Liu; Stamatis Georgopoulos; Athanasios Bakalakos; Nikolaos Karamichalakis; Sotirios Xydonas; Michael Efremidis; Antonios Sideris
Journal:  World J Cardiol       Date:  2016-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.